Boston Children's Hospital ( Site 0089)

Boston, Massachusetts 02115

0 studies enrolling now · 2 studies all time

What they study most

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome, PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)

Studies at this site

• A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006) — Running, not enrolling
• Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002) — Stopped early